Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues

Hepatitis C virus (HCV) infection is currently one of the main causes of cirrhosis and hepatocellular carcinoma (HCC) at a global level. Recently, a new generation of direct-acting antiviral agents (DAAs) has entered the HCV treatment landscape, providing impressively high rates of sustained virolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Tampaki, Maria, Savvanis, Spiros, Koskinas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191866/
https://www.ncbi.nlm.nih.gov/pubmed/30386116
http://dx.doi.org/10.20524/aog.2018.0306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191866/
https://www.ncbi.nlm.nih.gov/pubmed/30386116
http://dx.doi.org/10.20524/aog.2018.0306

Ejemplares similares